Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
10.6M
-
Shares change
-
+2.76M
-
Total reported value, excl. options
-
$158M
-
Value change
-
+$42.1M
-
Number of buys
-
38
-
Number of sells
-
-17
-
Price
-
$14.96
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2015
66 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q1 2015.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.6M shares
of 46.4M outstanding shares and own 22.84% of the company stock.
Largest 10 shareholders include Broadfin Capital, LLC (2.13M shares), FEDERATED INVESTORS INC /PA/ (1.49M shares), VANGUARD GROUP INC (853K shares), BlackRock Fund Advisors (820K shares), Sectoral Asset Management Inc (734K shares), JPMORGAN CHASE & CO (617K shares), Pictet Asset Management Ltd (561K shares), DEERFIELD MANAGEMENT CO (449K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (325K shares), and UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (310K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.